RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Invus
I

Invus portfolio

Invus has 25 portfolio companies on record at Recent Funding, with 9 investments in the last 12 months.

Website: invus.com.
Type: Crossover fund.
Portfolio on Recent Funding: 25.
Deals, last 12 months: 9.
Rounds led: 1 of 24.
Capital in their rounds: $3.28B.
Latest deal: Soufflé Therapeutics · Oct 13, 2026.
About this page

It is a crossover fund based in New York, US, founded in 1985. It led 1 of the 24 rounds it joined. Its most recent investment on record is Soufflé Therapeutics's $135M Series B+ round in October 2026, alongside TAS Partners, Leaps by Bayer, Vida Ventures and 6 others. By category, its portfolio leans toward Health and bio (17) and Logistics and mobility (4). It has co-invested with RA Capital Management, GV and ARCH Venture Partners, most often RA Capital Management (6 rounds).

About Invus

Firm type: Crossover fund.
Headquarters: New York, US.
Founded: 1985.
Stages: Seed, Series A, Series B, Series C, Growth, Late Stage.
Sectors: AI & Machine Learning, Biotech, Consumer, Crypto & Web3, Fintech, FoodTech, Healthtech, Marketplaces, SaaS, Travel & Hospitality.
Portfolio companies: 1.
Exits: 0.
Rounds led: 3.

What Invus invests in

Invus recent investments

How Invus invests

StageDealsCapital in rounds
Series B+ 18 75%$2.58B
Series A 6 25%$701M
YearDealsCapital in rounds
2019 1 4%$56M
2020 1 4%$59M
2021 3 13%$245M
2022 3 13%$547M
2023 3 13%$382M
2024 4 17%$685M
2025 1 4%$120M
2026 8 33%$1.19B

Invus portfolio companies

CompanyRound with InvusTotal raisedLatest raise
SSoufflé Therapeutics
Health and bio
Series B+ · $135M$335MOct 13, 2026
Series B+
UUniversal Quantum
Robotics and hardware
Series A · $100M$104.5MOct 8, 2026
Series A
MMatchpoint Therapeutics
Health and bio
Series B+ · $150M$250MOct 7, 2026
Series B+
PPrecision Neuroscience
Health and bio
Series B+ · $250M$303MSep 24, 2026
Series B+
LLifeMine Therapeutics
Health and bio
Series B+ · $75M$543MAug 6, 2026
Series B+
CCity Therapeutics
Health and bio
Series B+ · $99.5M$234.5MAug 8, 2026
Series B+
CContraline
Health and bio
Series B+ · $92.5M$105.45MJun 2, 2026
Series B+
CCorxel
Health and bio
Series B+ · $287M$287MJan 26, 2026
Series B+
TTriana Bio
Health and bio
Series B+ · $120M$120MDec 3, 2025
Series B+
RRapido
Logistics and mobility
Series B+ · $200M$719.2MMay 15, 2026
Series B+
CCardurion Pharmaceuticals
Health and bio
Series B+ · $260M$260MJul 16, 2024
Series B+
BBright Peak Therapeutics
Health and bio
Series B+ · $90M$125MAug 17, 2026
Series B+
OOrbital Therapeutics
Health and bio
Series A · $270M$270MAug 3, 2025
Series A
FFlare Therapeutics
Health and bio
Series B+$167MJun 30, 2026
Series B+
NNoema Pharma
Health and bio
Series B+ · $112M$171MNov 4, 2025
Series B+
MMOMA Therapeutics
Health and bio
Series B+ · $150M$236MMay 10, 2022
Series B+
Ddbt Labs
Data and analytics
Series B+ · $222M$384.9MFeb 24, 2022
Series B+
AAsher Bio
Health and bio
Series B+ · $108M$218MApr 16, 2024
Series B+
BBooster
Climate and energy
Series B+ · $56M · lead$218MMay 25, 2022
Series B+
EEliseAI
Voice and audio AI
backer$710MSep 29, 2026
Series B+
PPayhawk
Stablecoins
backer$243.57MJan 7, 2026
round
MMirador Therapeutics
Health and bio
backer$650MJan 13, 2026
Series B+
DDorsia
Commerce and retail
backer$50MFeb 14, 2025
Seed
BBrex
Fintech
backer$982MJan 22, 2026
Series A
WWithin
AI agents
backer$70MJun 24, 2024
round

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 24 rounds on Recent Funding that name Invus. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Invus, which is a subset of its real portfolio. API: /api/v1/investors/invus (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy